The administration of US President Donald Trump has selected the 5 most potential companies to produce the Covid-19 pandemic vaccine. According to The New York Times on 3-6, some secret sources said the White House will issue a notice on this issue in the coming weeks.
This is an important step in the effort to realize the US ambition to “produce several hundred million doses of vaccine against Covid-19 by early 2021”.
According to sources, the 5 companies mentioned above include Moderna (USA), AstraZeneca cooperation group – Oxford University (UK) and 3 “giants” of pharmaceutical industry Johnson & Johnson (USA), Merck (Germany), Pfizer (America). Each company has its own approach.
The vaccine development programs of Moderna, Johnson & Johnson and the Oxford team – AstraZeneca have so far received a total of US $ 2.2 billion in funding from the US Federal Fund. The above list will help the above companies receive additional funding from the US government, support the conduct of clinical trials as well as financial and logistical support to build production facilities despite the Whether the vaccine is developing or not.
Two of the vaccine candidates chosen by President Donald Trump’s administration, developed by Moderna and scientists at Oxford University, are now in the second phase of testing, meaning their effectiveness. is being tested on many people.
Other countries, including China, are also working to make vaccines. This race raises fears that vaccines may be supplied under “nationalism” rather than on actual needs.
Based on this situation, Handelsblatt newspaper said that Germany and three other members of the European Union (EU) – France, Italy and the Netherlands – are forming a new alliance to ensure the vaccine against Covid. -19, when developed successfully, will be divided equally throughout the world and the EU will not be “lost” compared to the US and China in the vaccine race.
Meanwhile, according to Reuters, British Prime Minister Boris Johnson chaired a global online summit on vaccines to raise funds for the GAVI vaccine alliance. With the participation of representatives from more than 50 countries, the conference aims to raise at least $ 7.4 billion for GAVI so that by 2025, the alliance could vaccinate an additional 300 million children in other countries. The world’s poorest, helps fight diseases like polio, diphtheria and measles.